• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BRAINLAB AG CRANIAL NAVIGATION SOFTWARE (VERSION 3.1); IMAGE GUIDED SURGERY SYSTEM/INSTRUMENT, STEREOTAXIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BRAINLAB AG CRANIAL NAVIGATION SOFTWARE (VERSION 3.1); IMAGE GUIDED SURGERY SYSTEM/INSTRUMENT, STEREOTAXIC Back to Search Results
Model Number 22216A
Device Problems Use of Device Problem (1670); Improper or Incorrect Procedure or Method (2017); Device Handling Problem (3265)
Patient Problems No Consequences Or Impact To Patient (2199); No Known Impact Or Consequence To Patient (2692)
Event Date 12/07/2018
Event Type  Injury  
Manufacturer Narrative
A risk to the patient's health could not be excluded for these specific circumstances, since potentially brain tissue was resected in another location than intended, with the brainlab device involved.A comprehensive investigation by brainlab regarding this specific event is currently ongoing and final conclusions are pending.Brainlab plans to issue a follow-up report to the fda upon completion of investigation.
 
Event Description
A biopsy was planned to be performed with the cranial navigation system 3.1 (on (b)(6) 2018).During the procedure the surgeon: performed the initial patient registration to match the virtual display of the preoperative scan to the current patient anatomy.Verified the accuracy of registration with a very good result.Obtained the biopsy, but pathology was not able to give a diagnosis (other than either normal brain or hyperactive cells indicating sample was taken on tumor margin).No negative clinical effects were reported for this patient due to this issue, nor any remedial actions that would have been necessary.
 
Manufacturer Narrative
A risk to the patient's health could not be excluded for these specific circumstances, since a biopsy was performed in another location in the brain than intended, with the brainlab device involved, although: there is no indication of a systematic error or malfunction of the brainlab navigation device, and according brainlab measures to minimize this anticipated risk as low as reasonably practicable are already in place.According to the hospital, the overall procedure was successful as intended, there was no harm to critical structures nor any other negative clinical effect to the patient due to this issue (also not due to anesthesia extended approximately by one hour), there were no further remedial actions necessary for this patient due to this issue, and this issue has not led to any hospitalization delays.According to the results of the brainlab investigation and the information provided by the hospital, it can be concluded that the root cause for the observed approximated 5 mm deviation of the navigation display compared to the actual patient anatomy is: a less than ideal scan (distortion correction not enabled in the scan protocol) apparently used for trajectory planning, which led to a deviation of the planned/intended location of the lesion and trajectory (as seen in the scan and displayed by navigation) from its physical location in the actual patient anatomy.Deviations of this nature cannot be recognized by or seen in the navigation system.Additionally, a less than ideal scan (with variable slice thickness, which is attributed to inadequate scanner settings) used for registration and navigation, that could have also led to a less than ideal registration result.To a lesser extent, a further contributing factor is: no new ndi drms were used for unsterile equipment; this may lead to artifacts caused by reflections when reusing old drms, and especially during registration may cause an inaccuracy.Apparently the deviation has not been recognized by the user with the necessary continued verification of accuracy throughout the procedure.There is no indication of a systematic error or malfunction of the brainlab navigation device.Corresponding brainlab measures to minimize this anticipated risk as low as reasonably practicable are already in place.Brainlab intends to re-iterate the relevant topics regarding the use of the device to this customer.
 
Event Description
A cranial surgery for biopsy (to obtain a diagnostic sample) was planned to be performed with the aid of the brainlab cranial navigation system version 3.1 (on (b)(6) 2018).The tumor dimension was about 2.3 mm in diameter; it was located about 4.4 cm from the surface in the coronal plane and 5.2 cm in the sagittal plane.Registration markers were placed on the patient head, and pre-operative mri scans were acquired on the surgery day, for use with navigation.During the procedure the surgeon: positioned the patient in supine orientation and attached the 4 sphere radiolucent reference array for navigation.Performed the initial patient registration on the pre-operative mri scan (to match the display of the navigation to the current patient anatomy).Verified accuracy of the registration and determined it good for this procedure.Draped the patient and exchanged the unsterile reference array for a sterile one, verified accuracy and confirmed it to be good for this procedure.Attached the frameless biopsy system to the skull clamp.Created a burr hole (15 mm) with aid of navigation (position determined using the pointer).Aligned the frameless biopsy system along a pre-planned trajectory.Took samples using the pre-calibrated disposable biopsy needle.Obtained information from pathology that the sample are normal brain tissue or hyperactive cells (indicating sample was taken on tumor margin and not in the center as intended).Decided to continue to use navigation as an aid until he was able to obtain a diagnostic sample (approx.10 samples were taken in multiple depths, instead of initially planned 4 samples).According to the surgeon, the overall procedure was successful as intended, there was no harm to critical structures nor any other negative clinical effect to the patient due to this issue (also not due to anesthesia extended approximately by one hour), there were no further remedial actions necessary for this patient due to this issue, and this issue has not led to any hospitalization delays.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CRANIAL NAVIGATION SOFTWARE (VERSION 3.1)
Type of Device
IMAGE GUIDED SURGERY SYSTEM/INSTRUMENT, STEREOTAXIC
Manufacturer (Section D)
BRAINLAB AG
olof-palme-strasse 9
münchen, 81829
GM  81829
MDR Report Key8177886
MDR Text Key130783273
Report Number8043933-2018-00050
Device Sequence Number1
Product Code HAW
UDI-Device Identifier04056481132439
UDI-Public04056481132439
Combination Product (y/n)N
PMA/PMN Number
K092467
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/19/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number22216A
Device Catalogue Number71201A
Was Device Available for Evaluation? Yes
Date Manufacturer Received12/07/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-